James Kling | Aug 30, 1998 | 6 min read
HOW IT WORKS: This diagram shows how Genzyme's SAGE method flows from one stage to another. In 1997, Genzyme Corp. of Cambridge, Mass., was shopping for new technology. "We were creating a cancer company, to put together a group of technologies that would give us a gene-based approach to cancer drug discovery," recalls Susan Primrose, director of business development at the now-formed Genzyme Molecular Oncology (GMO) in Framingham, Mass. They found a key to their project in SAGE (Serial Anal